4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-014057
Director sold 13,135 shares at an average $5.71 ($74,970)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Akirov Alfred Director | 2013-03-06 | Sale | −2,000 | $5.68 | $11,360 | 5,084,046 | I |
| Akirov Alfred Director | 2013-03-06 | Sale | −2,000 | $5.69 | $11,380 | 5,082,046 | I |
| Akirov Alfred Director | 2013-03-06 | Sale | −700 | $5.71 | $3,997 | 5,081,346 | I |
| Akirov Alfred Director | 2013-03-07 | Sale | −5,000 | $5.71 | $28,550 | 5,076,346 | I |
| Akirov Alfred Director | 2013-03-07 | Sale | −3,435 | $5.73 | $19,683 | 5,072,911 | I |
| Open-market sales · 13,135 sh · avg $5.71 · $74,970 | |||||||
Loading xslF345X03/v337608_4.xml…